《LANCET,4月2日,Monitoring behavioural insights related to COVID-19》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-04-03
  • Monitoring behavioural insights related to COVID-19

    Cornelia Betsch

    Lothar H Wieler

    Katrine Habersaat

    on behalf of theCOSMO group†

    Show footnotes

    Published:April 02, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30729-7

    The rapidly evolving coronavirus disease 2019 (COVID-19) pandemic is placing an overwhelming burden on health systems and authorities to respond with effective and appropriate interventions, policies, and messages. A critical element in reducing transmission of the virus is rapid and widespread behavioural change. Evidence shows that a perceived lack of consistency, competence, fairness, objectivity, empathy, or sincerity in crisis response in the public could lead to distrust and fear.1 Conversely, when the public perceives measures as having these characteristics, as well as being easily understood and communicated through trusted and accessible channels, and when the necessary services are available, people are able to make informed choices, protect themselves, and comply with recommended practices.

  • 原文来源:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30729-7/fulltext
相关报告
  • 《LANCET,4月2日,Monitoring the COVID-19 epidemic in the context of widespread local transmission》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-05
    • Monitoring the COVID-19 epidemic in the context of widespread local transmission Alberto L García-Basteiro Carlos Chaccour Caterina Guinovart Anna Llupià Joe Brew Antoni Trilla et al. Published:April 02, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30162-4 Coronavirus disease 2019 (COVID-19) is a novel viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first detected in Wuhan, China, in December, 2019.1 Given the fast spread, the severity of disease, the increasing number of cases outside China, and the number of affected countries, WHO declared the rapid spread of SARS-CoV-2 a pandemic on March 11, 2020.2 The availability of reliable surveillance platforms is crucial to monitor the COVID-19 epidemic in a timely manner and to respond with adequate control measures. Since the beginning of the outbreak, different countries have used different testing approaches and criteria, depending on their resources and capacity.
  • 《LANCET,6月4日,Active case finding with case management: the key to tackling the COVID-19 pandemic》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-05
    • Active case finding with case management: the key to tackling the COVID-19 pandemic Prof Zhongjie Li, PhD * Qiulan Chen, PhD * Prof Luzhao Feng, PhD Lance Rodewald, MD Yinyin Xia, PhD Hailiang Yu, MMed et al. Show all authors Show footnotes Published:June 04, 2020DOI:https://doi.org/10.1016/S0140-6736(20)31278-2 Summary COVID-19 was declared a pandemic by WHO on March 11, 2020, the first non-influenza pandemic, affecting more than 200 countries and areas, with more than 5·9 million cases by May 31, 2020. Countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. We describe China's strategies for prevention and control of COVID-19 (containment and suppression) and their application, from the perspective of the COVID-19 experience to date in China. Although China has contained severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and nearly stopped indigenous transmission, a strong suppression effort must continue to prevent re-establishment of community transmission from importation-related cases. We believe that case finding and management, with identification and quarantine of close contacts, are vitally important containment measures and are essential in China's pathway forward. We describe the next steps planned in China that follow the containment effort. We believe that sharing countries' experiences will help the global community manage the COVID-19 pandemic by identifying what works in the struggle against SARS-CoV-2.